Overview
Regis Rosa practices in Porto Alegre, Brazil. Mr. Rosa is rated as a Distinguished expert by MediFind in the treatment of Febrile Neutropenia. His top areas of expertise are Febrile Neutropenia, Severe Acute Respiratory Syndrome (SARS), COVID-19, and Agranulocytosis.
His clinical research consists of co-authoring 154 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Febrile Neutropenia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Febrile NeutropeniaMr. Rosa isDistinguished. Learn about Febrile Neutropenia.
- Advanced
- Acute Respiratory Distress Syndrome (ARDS)
- AgranulocytosisMr. Rosa isAdvanced. Learn about Agranulocytosis.
- COVID-19Mr. Rosa isAdvanced. Learn about COVID-19.
- DeliriumMr. Rosa isAdvanced. Learn about Delirium.
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- Cardiac ArrestMr. Rosa isExperienced. Learn about Cardiac Arrest.
- Cardiogenic ShockMr. Rosa isExperienced. Learn about Cardiogenic Shock.
- Cerebral HypoxiaMr. Rosa isExperienced. Learn about Cerebral Hypoxia.
- Heart AttackMr. Rosa isExperienced. Learn about Heart Attack.
- HypothermiaMr. Rosa isExperienced. Learn about Hypothermia.
- Long Haul COVIDMr. Rosa isExperienced. Learn about Long Haul COVID.